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Background: The role of DKK3 in vascular SMC differentiation has not been investigated.
Results: DKK3 induces myocardin expression via ATF6 signaling.
Conclusion: DKK3 is essential for the ESC-SMC differentiation.
Significance: This study provides the molecular mechanisms underlying DKK3 regulated ESC-SMC differentiation.
Smooth muscle cells (SMCs) are a key component of healthy
and tissue engineered vessels and play a crucial role in vascular
development and the pathogenic events of vascular remodeling
i.e. restenosis. However, the cell source from which they can be
isolated is limited. Embryonic stem (ES) cells that have the
remarkable capability to differentiate into vascular SMCs in
response to specific stimuli provide a useful model for studying
SMC differentiation. Previous studies suggested that dickkopf
homolog 3 (DKK3) has a role in human partially induced pluri-
potent stem cell to SMC differentiation. Here, we demonstrate
that the expression of DKK3 is essential for the expression of
SMC markers and myocardin at both the mRNA and protein
levels during mouse ES cell differentiation into SMCs (ESC-
SMC differentiation). Overexpression of DKK3 leads to further
up-regulation of the aforementioned markers. Further investi-
gation indicates that DKK3 added as a cytokine activates acti-
vating transcription factor 6 (ATF6), leading to the increased
binding of ATF6 on the myocardin promoter and increased its
expression. In addition, inhibition of extracellular signal-regu-
lated kinases 1/2 (ERK1/2) promotes the expression of ATF6
and leads to further increase of myocardin transcription. Our
findings offer a novel mechanism by which DKK3 regulates
ESC-SMC differentiation by activating ATF6 and promoting
myocardin expression.
Vascular smooth muscle cells SMCs4 are involved in the
physiological and pathological processes of the cardiovascular
system (1–3). In atherosclerosis, up to 70% of the mass in
lesions is estimated to be SMCs or SMC-derived components,
e.g. extracellular matrix (4, 5). The latest evidence suggests that
neointimal SMCs are, at least in part, derived from the differ-
entiation of multipotent stem cells (3). Therefore, understand-
ing the differentiation of stem cells to SMCs can provide new
insight of the disease development.
ES cells are characterized by unlimited self-renewal and the
potential to differentiate into SMCs in vitro (6, 7). They are a
useful alternative cell source to obtain SMCs that express spe-
cific cell markers such as -smooth muscle actin (SMA),
smooth muscle 22- (SM22), calponin, and smooth muscle
myosin heavy chain (SMMHC) (8, 9). Recent work has revealed
that DKK3 can regulate human partially induced pluripotent
stem cell toward SMC differentiation and is useful for generat-
ing tissue-engineered vessels (10). DKK3 is also known as REIC
(Reduced Expression in Immortalized Cells), as it was found to
be down-regulated in many immortalized cell lines and a num-
ber of established human cancer lines (11, 12), functioning as a
natural tumor suppressor in human tissues (13). However, little
is known about DKK3 functioning during cardiovascular
development.
The overall process of SMCdifferentiation is extremely com-
plex and involves the co-operative interaction of many factors.
Myocardin, the transcriptional co-factor of serum response
factor (SRF), is found to be required for the expression of many
SMC differentiation markers and expressed at higher levels in
contractile SMCs than in synthetic SMCs (14). It is crucial in
the initial differentiation of SMCs during development (15, 16).
Overexpression of myocardin induces ES cells to express mul-
tiple SMC genes including -SMA, SM22, and SMMHC (17).
In atherosclerotic lesions, excess lipids, homocysteinaemia,
hypoxic stress and other inflammatory and toxic signals can
stimulate endoplasmic reticulum (ER) stress and activate the
unfolded protein response in cells (18–20), which activate
ATF6 (21). ATF6 is a transmembrane transcription factor that
is regulated by ER stress and is involved in adipogenesis and
odontoblastic differentiation (22, 23). However, the involve-
* This work was supported by grants from the British Heart Foundation (RG/
14/6/31144), Oak Foundation, and Queen Mary University of London. The
authors declare that they have no conflicts of interest with the contents of
this article.
Author’s Choice—Final version free via Creative Commons CC-BY license.
□S This article contains supplemental movies.
1 Both authors contributed equally to this work.
2 To whom correspondence may be addressed: Inst. of Bioengineering,
Queen Mary University of London, London E1 4NS. Tel.: 44-2078828871;
E-mail: wen.wang@qmul.ac.uk.
3 To whom correspondence may be addressed: Cardiovascular Division,
King’s College London BHF Centre, London SE5 9NU. Tel.: 44-2078485322;
E-mail: qingbo.xu@kcl.ac.uk.
4 The abbreviations used are: SMC, smoothmuscle cell; ATF6, activating tran-
scription factor 6; ChIP, chromatin immunoprecipitation; c-PCR, conven-
tional PCR; DKK3, dockkopf homolog 3; DM, differentiation medium; ER,
endoplasmic reticulum; ERK, extracellular signal-regulated kinases; ES cell,
embryonic stem cell; ESC-SMC differentiation, ES cells differentiation
towards SMCs; Q-PCR, quantitative PCR; RDU, relative densitometry units.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 290, NO. 32, pp. 19844–19852, August 7, 2015
Author’s Choice © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
19844 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 32•AUGUST 7, 2015
ment of ATF6 in SMCdifferentiation has not yet been found. In
the present study, we investigated the role of DKK3 during
mouse ESC-SMC differentiation as well as the mechanism for
this process.
Experimental Procedures
Cell Culture and Differentiation—Detailed protocols for
mouse ES cell (ES-D3 cell line, CRL-1934; ATCC, Manassas,
VA) culture and SMCdifferentiationwere previously described
(8, 25). Briefly, ES cells were seeded on gelatin (Sigma) coated
flasks and cultured in culture medium (CM), which included
Dulbecco’sModified EssentialMedium (DMEM) (ATCC), 10%
Embryomax Fetal Bovine Serum (FBS) (Millipore), 10 ng/ml
Leukemia Inhibitor Factor (LIF) (Millipore), 0.1 mM 2-mercap-
toethanol (2-ME) (Life Technologies™), 100 units/ml penicillin,
and 100g/ml streptomycin (Life Technologies) and 2mM glu-
tamine (Life Technologies). They were split every other day in a
ratio of 1:10. For SMC differentiation, undifferentiated ES cells
were seeded on mouse collagen IV (5 g/ml)-coated flasks or
plates in differentiationmedium (DM) that contains-minimal
essential medium (aMEM Invitrogen) supplemented with 10%
FBS, 0.05 mM 2-ME, 100 units/ml penicillin, 100 g/ml strep-
tomycin, and 2 mM glutamine. DM was refreshed every day
after the second day of differentiation. The cells were cultured
in DM for 4–8 days after which they were harvested and fur-
ther analyzed.
Cell Contractility Assays—ES-derived SMCs were washed
with PBS, stimulated with 1 mM carbachol or 40 mM KCl (Sig-
ma-Aldrich) in the DM, and monitored under the microscope
up to 45 min. Movies of the same field were recorded with
time-lapse phase contrast microscopy.
Lentiviral Particle Construction and Infection—293-T cells
were transfected with the lentiviral vector MISSION shDKK3
plasmid DNA (Sigma), the packaging plasmids pCMV-dR8.2
(Addgene) and pCMV-VSV-G (Addgene) using Fugene6 (Pro-
mega). The supernatant containing the lentiviruswas harvested
48 h later and filtered, and the transduction unit (TU) was cal-
culated, as previously described (26). A non-targeting short
hairpin ribonucleic acid (shRNA) vector was used to generate
the control particles. For the lentiviral infection, mouse ES cells
were differentiated for 2 days prior to infection. The cells were
then incubated with shDkk3 or non-targeting control (shCtl)
(1  107 TU/ml) in DM supplemented with 10 g/ml of poly-
brene (Millipore) overnight. Subsequently, freshDMwas added
to the cells after which they were incubated for another 2 days
before harvesting.
Adenoviral Gene Transfer—ThemouseDkk3 adenovirus was
purchased from Abm (Applied Bio Materials) and amplified in
HEK293 cells as instructed by the company. The titration of the
adenovirus was assessed at 2.3  106 IFU/l by using the
QuickTiterTM Adenovirus Titer ELISA Kit from Cambridge
Bioscience (cat. no VPK-110). For the adenovirus infection,
cells after 2 days of differentiation were infected with the Ad-
Null (control particles) or Ad-Dkk3 adenovirus at an MOI of
345 and harvested 2 days later.
Transfection—For the overexpression ofATF6 or silencing of
ATF6, cells were seeded on a collagen IV substrate and main-
tained in DM for 2 days prior to transfection. 0.4 g of plasmid
was mixed with 1.2 l of FuGENE 6 transfection regent (Pro-
mega) or Lipofectamine RNAiMAX Transfection Reagent
(Life Technologies) per well of a 6-well plate. The solution was
then applied to the cells to be transfected. The medium was
changed to fresh DM after 6 h. Cells were harvested 2 days after
transfection.
Conventional PCR (c-PCR) and Quantitative RT-PCR
(Q-PCR)—Total RNAwas extracted using the RNeasyMini Kit
(Qiagen) according to the manufacturer’s protocol. 1 g of
RNA was reverse transcribed into cDNA with random primers
by MMLV reverse transcriptase (Promega). 20–50 ng cDNA
(relative to RNA amount) was amplified by c-PCR with
TaqDNA polymerase (Invitrogen) or Q-PCR with SYBR green
(Qiagen) and the appropriate primers.
Immunoblotting—Cells were harvested and lysed in lysis
buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, and 1 mM EDTA,
pH 8.0) supplementedwith protease inhibitors and 0.5%Triton
by sonication for whole cell lysate. 30–50 g of protein was
separated by SDS-PAGEwith 8%Tris-glycine gel and subjected
to standard Western blot analysis.
Indirect Immunofluorescent Staining—Cells were seeded on
gelatin or collagen IV coated slides (Millipore) and cultured in
CM or DM. They were fixed with 4% paraformaldehyde for 10
min and then permeabilized with 0.1% Triton X-100 for 10min
at room temperature. 5% serum (same species as the secondary
antibody) was used to block nonspecific binding for 1 h at room
temperature. The primary antibody was applied and incubated
at 4 °C overnight. The samples were then incubated with the
appropriate secondary antibodies (Alexa Fluor) for 45min at 37
°C and counterstained with DAPI (4, 6-diamidino-2-phe-
nylindole) for 2 min at room temperature. Finally, slides were
mounted with fluorescent mountingmedia (Dako), and images
were taken with the fluorescence microscope (Olympus). For
every set of experiments, images were captured at the same
levels of exposure, gain and offset.
Enzyme-linked Immunosorbent Assay—ELISA was per-
formed according to the manufacture’s specification (Sino
Biolocial Inc.) to measure the level of mouse DKK3 in cell cul-
ture supernatants.
Co-immunoprecipitation—Cells were infected with the Ad-
Null or Ad-Dkk3 adenorius. After infection, the medium was
changed to freshDMwith different dilutions of DKK3 antibody
(GenScript). The supernatants were harvested, and the com-
plexes were retrieved by resin (Sigma) and precipitated for
immunoblotting analysis.
Chromatin Immunoprecipitation (ChIP) Assay—ChIP was
conductedwith the ChIPAssay Kit (Millipore) according to the
protocol provided. Briefly, ES cells differentiated for 2 days
were infected with Ad-Null or Ad-Dkk3 adenovirus. DKK3
antibody was used in the supernatant after the overexpression
ofDKK3 to block releasedDKK3 cytokine. Cells were harvested
after cross-linking by formaldehyde. The cross-linked chroma-
tin was sheared by sonication, producing DNA-protein frag-
ments of 300–1000 base pairs (bp) in length.MouseATF6 anti-
body (ChIP grade, Abcam) (IgG as control) coupled to agarose
beads was used to immnunoprecipitate the specific complex.
The DNA-protein complex was then reversed by digestion of
the protein to free the DNA. Finally the purified DNAwas used
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for PCR analysis. The specific primers designed for detecting
the binding site of ATF6 are: Forward: GCTGATAACCT-
CAGGGGCTC; Reverse: CCTTGCCACTCCCATCCATT.
Results
DKK3 Is Up-regulated during ESC-SMC Differentiation—
Mouse ES cells were seeded on collage IV-coated flasks and
cultured in DM to stimulate SMC differentiation. It was found
that SMCmarkerswere successfully induced at both themRNA
(Fig. 1A) and the protein (Fig. 1, B andC) levels at day 4 and day
8, while the expression ofDKK3was also increased during ESC-
SMC differentiation (Fig. 1, B and C). The cells changed from
spherical colonies (Fig. 1D) to flattened spindle-shaped mor-
phology after 8 days of differentiation (Fig. 1E). Importantly,
ESC-SMCs displayed the contractility in response to KCl stim-
ulation (Supplemental Movies). Immunofluorescent staining
FIGURE 1. DKK3 is up-regulated during ESC-SMC differentiation. For the differentiation, mouse ES cells were seeded on a collagen IV-coated flasks and
maintained in DM. Samples were harvested at 4 days and 8 days of differentiation. Undifferentiated ES cells were used as a day 0 control. Q-PCR analysis
revealed up-regulation of a full panel of SMC specificmarkers (A) during differentiation.Gapdhwas used as an internal control. Data shownhere as themean
S.E. (two-tailedStudent’s t test: *,p0.05; **,p0.01; ***,p0.001). RepresentativeWesternblot image (B) andquantificationof three individual experiments
(C) showed SMA, SM22, calponin, and DKK3 protein were significantly increased at day 4. RDU, relative densitometry units. Bright field imaging revealed the
morphological differences between ES cells (D) and 8-day differentiated cells (E). Immunofluorescence staining (F) revealed that the undifferentiated ES cells
expressed low levels of DKK3 protein as well as SMC protein, while the cells seeded on collagen IV-coated plates and cultured in DM for 8 days showed a
significant increase of SMC markers and DKK3 protein. Supernatant samples were collected from undifferentiated ES cells and after 2 days and 4 days
differentiation. ELISAwas performed tomeasure the concentration of DKK3 protein, and the final results were normalized to every 106 cells (data shown as the
mean S.E. of three individual experiments) (G).
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showed a significant increase in the expression of DKK3 and
SMCmarkers after 8 days of differentiation (Fig. 1F).Moreover,
the detection of secreted DKK3 protein (cytokine) in the cell
culture supernatant revealed an increase of DKK3 secretion
during the ESC-SMC differentiation (Fig. 1G).
DKK3 Regulates ESC-SMC Differentiation—To uncover
whether DKK3 played an important role during the mouse
ESC-SMC differentiation process, lentiviral particles contain-
ing shDkk3were introduced to knockdownDKK3 expression in
in vitro experiments. Cells infected with ShCtl were used as
control group. ES cells were cultured in DM for 2 days before
infection. Samples were harvested 2 days after infection. The
cells infected with shDkk3 displayed a morphology more simi-
lar to ES cells compared with shCtl (Fig. 2A). Q-PCR results
demonstrated that knockdown of DKK3 dramatically down-
regulated the transcription of all the SMC markers (Fig. 2B).
Western blot analysis also revealed a significant down-regula-
tion of SMC specific markers as well as DKK3 protein (Fig. 2, C
and D). To further investigate the role of DKK3 during ESC-
SMC differentiation, ES cells were pre-differentiated for 2 days
before adenoviral particles containing Ad-Dkk3 or Ad-Null
were introduced. Samples were harvested 2 days after infec-
FIGURE2.DKK3regulatesESC-SMCdifferentiation.For the shutdownofDKK3experiment, ES cellswere infectedwith lentiviruses containing shCtlor shDkk3
(107 TU/ml complemented with 10 g/ml polybrene) after 2 days of pre-differentiation. The cells displayed different morphologies (A) 2 days post-infection
andwere subjected toQ-PCR (B) andWestern blot (C) analysis for SMC specificmarkers. Quantification ofWestern blot images (mean S.E. of three individual
experiments) revealed a significant down-regulation of SMC specific markers as well as DKK3 at the protein level (D). For the overexpression of DKK3, ES cells
were cultured inDM for 2 days before infectionwith adenovirus particles containing Ad-Null or Ad-Dkk3. Sampleswere harvested 2 days after infection. Q-PCR
(E and F) revealed a further induction of SMCmarkers, such as SM22, SMA, SMMHC after overexpression of DKK3 and Western blot (G) showed up-regulation
of SMC markers. In addition, ELISA of the supernatant after overexpression of DKK3 revealed a considerable increase in DKK3 cytokine release (H). The final
results were normalized to every 106 cells (data shown as the mean S.E. of three individual experiments).
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tion. DKK3 (Fig. 2E) and SMCmarkers (Fig. 2, F and G) were
found to be up-regulated after overexpression of DKK3. In
addition, the secretion of DKK3 cytokine in the cell culture
supernatant was also increased after DKK3 overexpression
(Fig. 2H).
DKK3 Regulates Myocardin Expression—Myocardin is a
master regulator of smooth muscle gene expression and was
found to be up-regulated in parallel with DKK3 during
mouse ESC-SMC differentiation at both the mRNA (Fig. 3A)
and protein (Fig. 3B) levels. In addition, shutdown of DKK3
significantly reduced myocardin expression (Fig. 3, C and D)
while overexpression of DKK3 led to further up-regulation
of the myocardin expression (Fig. 3, E and F). Since DKK3 is
a secreted protein, it was of great importance to assess
whether DKK3 was exerting its role as a cytokine or as an
intracellular component with regards to the regulation of
myocardin. To uncover this, a DKK3 antibody was employed
to block the effect of extracellular DKK3 upon DKK3 over-
expression. ES cells were pre-differentiated for 2 days and
then infected with Ad-Dkk3. Subsequently, DKK3 antibody
or IgG were added in different concentrations (0.2, 1, 5
g/ml) to the supernatants. It was found that 1 g/ml DKK3
antibody was sufficient to block the extracellular DKK3 cyto-
kine (Fig. 3G) and therefore was chosen as the optimum
concentration for further experiments. Cell samples were
harvested and assessed by Q-PCR (Fig. 3H). It was revealed
that blocking of DKK3 cytokine ablated the induction of
myocardin transcription upon DKK3 overexpression. These
FIGURE 3. DKK3 regulates myocardin expression during ESC-SMC differentiation. During ESC-SMC differentiation, the expression of myocardin was
significantly up-regulated from day 2 to day 4 at both the mRNA (A) and protein (B) levels. Shutdown of DKK3 led to a significant decrease of myocardin
expression at mRNA (C) and protein (D) levels while the overexpression of DKK3 induced further up-regulation of myocardin expression at both themRNA (E)
and protein (F) levels. To investigate whether the secretion of DKK3 cytokine was important for the DKK3-inducedmyocardin expression, DKK3 antibody was
used to block the effect of DKK3 in supernatant. IgG was used as a control. Addition of DKK3 antibody sufficiently blocked the released cytokine after
overexpression of DKK3 (G) andQ-PCR analysis (H) revealed thatmyocardin transcription is significantly reduced (mean S.E. of three individual experiments,
***, p 0.001) upon blocking the secreted DKK3.
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results suggest that DKK3 exerts its function on myocardin
expression via its secretion as a cytokine.
DKK3ModulatesMyocardin Induction via ATF6 Signaling—
To clarify the underlying mechanism of DKK3 mediated myo-
cardin induction, the expression of a series of transcription fac-
tors with potential binding sites in the upstream promoter
region of the myocardin was assessed. 2 days pre-differentiated
ES cells were infected with Ad-Null or Ad-Dkk3 and main-
tained in DM with or without 1 g/ml of DKK3 antibody.
Q-PCR analysis was used to screen the expression of these can-
didates at the mRNA level (Fig. 4A). Finally, ATF6 was selected
due to its up-regulation upon DKK3 overexpression and
reduced expression as blocking of DKK3 cytokine at both the
mRNA (Fig. 4A) and the protein (Fig. 4, B and C) levels. To
elucidate whether ATF6 was involved in the regulation of myo-
cardin expression, ATF6 gene was transiently overexpressed by
transfection at day 2 of ESC-SMC differentiation or it was
silenced at day 2 with siRNA upon the DKK3 induced ESC-
SMC differentiation process. It was demonstrated that up-reg-
ulation of ATF6 led to further induction of myocardin expres-
sion at both the mRNA (Fig. 4D) and protein (Fig. 4E) levels,
whereas the shutdown of ATF6 significantly reduced the tran-
FIGURE 4. DKK3 regulates myocardin via transcription factor ATF6. Treated cells were harvested for PCR analysis indicating the mRNA levels of ATF6
increased upon DKK3 overexpression and reduced upon blocking with 1 g/ml of DKK3 antibody (A). Western blot analysis (B) and quantification of three
individual experiments (C) confirmed the changes of ATF6 at the protein levels. ES cells were pre-differentiated for 2 days and transfected with vectors to
overexpressATF6. Thecellswereharvested2days later, and the result revealedan increaseofmyocardinexpressionatboth themRNA (D) andprotein (E) levels.
The shutdown of ATF6 by siRNA significantly reducedmyocardin transcription (F). Shutdown of ATF6 after DKK3 overexpression led to reduced expression of
SMCmarkers (G). ChIP assayswereperformed to confirm the interactionbetweenATF6 and theMYOCDpromoter. Q-PCR (H) and c-PCR (I) analysis showed that
overexpression of DKK3 led to increased binding between ATF6 and the myocardin promoter, an effect which can be diminished after blocking the secreted
DKK3.
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scription of myocardin (Fig. 4F). Furthermore, it was shown
that shutdown of ATF6 reduced the SMC induction of DKK3
overexpression (Fig. 4G). The binding interaction of ATF6 and
the myocardin promoter was confirmed by ChIP assay. The
results fromQ-PCR (Fig. 4H) and c-PCR (Fig. 4I) analysis dem-
onstrated that there was an increased binding between ATF6
and the myocardin promoter upon DKK3 overexpression. Fur-
thermore, the aforementioned induction was ablated upon
blocking of the DKK3 cytokine in the supernatant. These
results present novel findings by which DKK3 can induce myo-
cardin expression via ATF6 signaling during ESC-SMC
differentiation.
ERK Signaling Is Involved in the DKK3 Induced ESC-SMC
Differentiation—It has recently been reported that MEK/ERK
signaling plays a role on ATF6 activity in human melanoma
cells (27, 28). In this study,we found that shutdownofDKK3 led
to activation of ERK1/2 (pERK1/2) (Fig. 5A). Moreover, block-
ing ofDKK3 cytokine also showed a regulation of pERK1/2 (Fig.
5B). To uncover whether ERK signaling played a role in our
system, the MEK/ERK inhibitor PD98059 was utilized. ES cells
were pre-differentiated for 2 days and then infected with Ad-
Dkk3. ERK inhibitor PD98059 or DMSO (vehicle control) was
added to cell culture medium after infection. The samples were
harvested 2 days later. It was found that ATF6was up-regulated
at both the mRNA (Fig. 5C) and protein (Fig. 5, D and E) levels
as ERK1/2was suppressed. The transcription ofmyocardin and
SMC specific markers was significantly increased upon treat-
ment with PD98059 during DKK3 induced ESC-SMC differen-
tiation (Fig. 5C). This suggests that DKK3 may be inhibiting
ERK signaling, which leads to the up-regulation of ATF6 myo-
cardin expression.
Discussion
It has been shown that ES cells can differentiate into SMCs
via mechanisms controlled by different signal transduction
pathways (8, 9, 29–31). However, themechanisms that regulate
ESC-SMC differentiation are extremely complicated and still
not well understood. Although DKK3 has been mainly associ-
atedwith cancer (11, 32, 33), it is found that recombinantDKK3
protein induces human monocyte differentiation to immature
dendritic cells (34). Moreover, recent work in our laboratory
has demonstrated that DKK3 plays a crucial role during partial-
ly-induced progenitor cell to SMC differentiation by induction
of SMC specific markers (10). The aforementioned findings
triggered our interest to further investigate the role of DKK3
during the differentiation of SMC from mouse ES cells. In the
present study, DKK3 protein is up-regulated in parallel with
SMC markers, including SMA, SM22, calponin, and
SMMHC. DKK3 is essential for ESC-SMC differentiation as
knockdown of DKK3 significantly reduced all the SMC specific
markers as well as the expression of the SMC master regulator
myocardin. Additionally, overexpression of DKK3 leads to a
further up-regulation of SMC markers and myocardin.
Because of the fact that myocardin regulates SMC marker
expression and is important for ESC-SMC differentiation (16,
35), we selected it to be studied further. Furthermore, we found
that overexpression of DKK3 highly induces the secretion of
DKK3 cytokine that ultimately leads to myocardin gene tran-
scription andmyocardin protein expression. Blocking of DKK3
cytokine in the culture medium ablated the aforementioned
effect, suggesting thatDKK3 can promotede novo transcription
of myocardin through its role as a cytokine. While trying to
understand how DKK3 was transcriptionally regulating myo-
cardin, a number of transcription factors that have the potential
to bind on the upstream promoter region of themyocardin was
investigated. It was found that among these candidates, ATF6
was the transcription factorwith significant expression changes
uponDKK3 overexpression and cytokine blocking. ATF6, a key
regulator of the ER stress, is known to regulate ER stress-medi-
ated apoptosis during chondrocyte differentiation (36). How-
ever, the role of ATF6 in SMC differentiation has not yet been
investigated. Experiments conducted in this study revealed that
the overexpression of ATF6 further inducesmyocardin expres-
sion, while shutdown of ATF6 diminished myocardin tran-
scription during DKK3 induced ESC-SMC differentiation (Fig.
6). The interaction between ATF6 and myocardin promoter
was then confirmed by ChIP assay. Taking together, we show
here for the first time that ATF6 serves as a transcription factor
of myocardin during DKK3 induced ESC-SMC differentiation.
FIGURE 5. Inhibition of ERK1/2 promotes DKK3 induced myocardin
expression. The cells were infected with shDKK3, and phosphorylated
ERK1/2 was detected byWestern blot analysis (A). Blocking of the DKK3 cyto-
kine after overexpression of DKK3 rescued the ERK1/2 activity (B). To test the
role of ERK1/2 in the DKK3 induced myocardin expression, the ERK signaling
inhibitor (PD98059)was used after overexpressionofDKK3. Cells treatedwith
PD98059 displayed an increase in the transcription of myocardin and SMC
markers (C). ATF6aswell as SM22were significantlyup-regulatedas shownby
Western blot analysis (D) and quantification of three individual experiments
(the mean S.E.) (E).
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Although theDKK family is known to be aWnt inhibitor, the
relationship between DKK3 and Wnt signaling is still contro-
versial (37, 38). Additional to Wnt signaling, DKK3 has also
been reported to regulate the TGF-/Smad signaling (39) and
ERK signaling (40). It is reported that DKK3 acts as a tumor
suppressor in human pancreatic cancer cells via the phosphor-
ylation of ERK (40). It is also suggested that ERK regulates pro-
liferation and migration in rat SMCs (41). In addition, onco-
genic activation of MEK/ERK signaling contributes to sustain
the activation of IRE1 and ATF6, which is important for mel-
anoma cell survival and promotes the pathogenesis of mela-
noma (27, 28). In this study, we explored the involvement of the
ERK pathway in SMC differentiation and its regulation of
ATF6, which has not yet been fully investigated.We found that
pERK1/2 is significantly up-regulated uponDKK3 shutdown or
when the DKK3 cytokine is blocked after DKK3 overexpres-
sion. Inhibition of MEK/ERK by its inhibitor PD98059 signifi-
cantly increases ATF6 expression at both the mRNA and pro-
tein levels and promotes myocardin transcription. The above
findings suggest a novel mechanism that DKK3 induces the
expression of myocardin via ATF6 signaling, which could be
mediated by inhibiting ERK pathways. Thus, targeting DKK3
might provide a new therapeutic strategy for intervention in
vascular diseases via regulation of SMC differentiation.
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